4. Issues of Ethnopharmacology in HIV Management
Interactions Between Herbal Products and Antiretrovirals
A primary concern regarding the concurrent use of herbal products and antiretrovirals and other HIV-related medications is the potential for herb-drug interactions, which could result in:
- Increased toxicity of the herb
- Decreased efficacy of the herb
- Increased antiretroviral toxicity
- Decreased antiretroviral efficacy
St. John's wort.
St. John’s wort (used to fight depression and anxiety) is associated with reduced plasma concentrations of the protease inhibitor indinavir, primarily due to St. John’s wort’s induction of hepatic enzymes involved in the metabolism of many antiretrovirals and other drugs. [Hennessy 2002, Pisciteilli 2001] Therefore coadministration of St. John’s wort and protease inhibitors or non-nucleoside reverse transcriptase inhibitors should be avoided. [Robertson 2007]
Garlic supplements.
Piscitelli and colleagues reported that coadministration of garlic supplements (used to treat hypertension and elevated cholesterol levels and to prevent certain cancers) with the protease inhibitor saquinavir is associated with a significant decrease in saquinavir plasma concentrations. [Piscitelli 2002] In addition, severe gastrointestinal adverse effects have been reported with the concomitant use of garlic supplements and the protease inhibitor ritonavir, which is commonly used to boost concentrations of other protease inhibitors. [Robertson 2007]
Echinacea purpurea.
Echinacea purpurea (used to fight infections, particularly colds and other upper respiratory conditions) is contraindicated in patients with chronic diseases such as diabetes, bronchial asthma, allergy, autoimmune deficiency, leukemia, collagenous disease, and HIV infection. Some of these contraindications are due to the exclusion criteria used in clinical trials of licensed medications and may represent only theoretical concerns. [DerMarderosian 2000, Miller 1998] Adverse effects associated with use of Echinacea purpurea are not common and consist primarily of allergic-type reactions. [Ernst 2002]
Because of the relatively widespread use of herbal treatments among HIV-positive patients, clinicians, pharmacists, and other practitioners should take care to obtain a complete history of a patient’s use of medications, herbs, and other supplements. Depending on the particular supplements that a patient may use, practitioners should perform any appropriate therapeutic monitoring. Practitioners should also discuss patients’ use of herbal or other natural products in a nonjudgmental manner that takes into consideration the relevant health-related beliefs and practices of the patient’s ethnic or cultural background. This discussion should include educating the patient regarding the potential benefits, risks, and contraindications of using such supplements. [Almuete Herbal Therapy]